NORMAL AND DIABETIC HUMAN SUBJECTS

A new high potency organic chromium yeast was investigated for its effect on blood control and serum lipids in a group of 23 normal and diabetic subjects which were sub-divided into normals, hyperglycaemics, insulin-dependent diabetics and non-insulin dependent diabetics. Each volunteer daily took 100 mg of yeast containing 218 μg of chromium for a period of six months. The blood and serum was analysed before supplementation and periodically throughout the study. Transient improvements in the various parameters occurred in all the groups in the early portion of the study. However, after six months of supplementation, the only group to statistically significantly benefit was the hyperglycaemic group. This group had improved blood glucose control, lowered serum lipids and a decreased risk of coronary heart disease